How can advanced printing technologies accelerate innovation in biomedical and pharmaceutical applications?
The Industrial Print Integration (IPI) Conference (24-25 November 2026 in Düsseldorf-Neuss) brings together leading researchers, technology developers, and industrial innovators to showcase the latest breakthroughs in functional printing, additive manufacturing, printed electronics, sensors, medical devices, and life science applications.
Previous editions featured presentations on printed electronics for healthcare, inkjet printing in medical applications, functional materials for medical devices and biosensors, and advanced manufacturing technologies enabling next-generation healthcare solutions. First confirmed highlights from this year’s programme include the Belgian start-up Antleron, “Biology-in-a-Smart-Box: Patient-centric Biomedical and Life Science Solutions Enabled by Multimaterial 3D Printing Platforms,” alongside new developments in stretchable and self-healable electronics from Hasselt University.
For biomedical and pharma companies seeking new manufacturing approaches, personalised healthcare solutions, smart diagnostics, or advanced medical devices, IPI offers a unique opportunity to discover emerging technologies and establish valuable innovation partnerships.
First-come visitors receive a 50% registration discount, and five complimentary VIP invitations are available for qualified biomedical and pharmaceutical brand owners.
Date: 24 – 25 November 2026
Venue: Crowne Plaza Düsseldorf/Neuss, Germany